Skip to content
Research Article Open access CC BY 4.0

Safety Profile and Toxicity Amelioration Strategies of Common Adverse Effects Associated with Anticancer Medications

Mallik Singaraju, Subish Palaian, Pathiyil Ravi Shankar, Sunil Shrestha

Journal of Pharmaceutical Research International · pp. 18–30 · Published 6 Jul 2020

10.9734/jpri/2020/v32i1130499

Abstract

More than half the cancer patients undergoing cancer chemotherapy develop adverse drug reactions (ADRs). Cancer chemotherapeutic agents have a lower risk-benefit ratio than other drug therapy and kill cancerous as well as the normal rapidly dividing cells including bone marrow cells, gastrointestinal epithelium, hair follicles, etc. Their main ADRs are nausea and vomiting, mucositis, constipation, diarrhea, hematological toxicities, cardiac toxicity, alopecia, gonadal toxicity, pulmonary toxicity, neurotoxicity, nephrotoxicity, etc. The severity of the adverse effects may range from mild nausea to life-threatening neutropenia. Administering premedication and antidotes are very vital in these patients. Upon the occurrence of adverse effects, immediate steps should be taken to manage them. Though the ADRs due to anticancer medications are not avoidable, careful monitoring of the patients and modulating the drug schedules/dosages can help in minimizing them. Healthcare professionals should also develop strategies to minimize the occupational hazards associated with these drugs.

Adverse drug reactions alopecia cancer chemotherapy hematological toxicity teratogenicity toxicity vomiting

Cited by 12

Effect of family-centered empowerment model on self-efficacy of children with leukemia

Omayma Mustafa Abu Samra, S. Hashem, H. Abozed · BMC Pediatrics · 2026

Beyond the common ground: Unmasking unique toxicity signatures of cisplatin, docetaxel, and fluorouracil with implications for head and neck cancer treatment.

Si-Min Li, Xiong Zhang, Fa Sun · Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2025

Nalirifox in the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC): A Comprehensive Review

Sattwikesh Paul, Aniket N. Lalaji, Sankha Shubra Saha · Journal of Neonatal Surgery · 2025

Potent Anti-Cancer Activity of 1-Dehydrodiosgenone from the Product of Microbial Transformation of Steroid Saponins

Quanshun Li, Shirong Feng, Yuanyuan Zhang · International Journal of Molecular Sciences · 2024

Knowledge and Performance of Mothers Having Children with Cancer Undergoing Chemotherapy

Elshaimaa Gamal Hasan, S. A. Mohamed, S. Ahmed · Minia Scientific Nursing Journal · 2020

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

12

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.